Request
Oligosynthesis Business Development in the Philippines
Over 95% of oligosynthesis occurs outside the Philippines. Looking for a partner to offer these services competitively locally.
Manila HealthTek Inc. is a pioneering Filipino biotechnology company advancing accessible, high‑quality diagnostics and digital health innovation. Known for developing the country’s first locally made COVID‑19 test kit, the company integrates molecular diagnostics, point‑of‑care technologies, and AI‑enabled platforms to strengthen health systems in low‑ and middle‑income settings.
Expanding beyond laboratory solutions, Manila HealthTek is building next‑generation AI + Healthcare Digital Twin technologies to support predictive public‑health modeling, outbreak readiness, and data‑driven decision‑making. At the primary‑care level, the company is developing AI‑Triage tools that enhance frontline assessment, streamline patient flow, and improve early detection of infectious and chronic diseases.
Anchored on scientific excellence and health equity, Manila HealthTek continues to grow its portfolio across diagnostics, digital health, and environmental monitoring—positioning itself as a key driver of biotechnology and AI‑powered healthcare innovation in the Philippines.
Business Areas
Healthcare Data
Value Chain
Request
Oligosynthesis Business Development in the Philippines
Over 95% of oligosynthesis occurs outside the Philippines. Looking for a partner to offer these services competitively locally.